Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nigeria to commercialise GMOs in 2015

Genetically modified crops for food use will become available for sale and planting in Nigeria in 2015, newswire AllAfrica reports. Minister of Science and Technology Professor Ita Ewa reportedly told an International Service for the Acquisition of Agri-Biotech Applications (ISAAA) conference that the country would commercialise GM crops in 2015. He added that the biosafety bill passed by the National Assembly on June 1st 2011 (Agrow No 618, p 25) would "soon" be signed by President Goodluck Jonathan. Professor Ewa claimed that GM crops had contributed to food security and sustainability by increasing world crop production between 1996 and 2011. "Sudan joined South Africa, Burkina Faso and Egypt, to bring the number of African countries commercialising biotech crops to four. Five countries: Cameroon, Kenya, Malawi, Nigeria and Uganda, conducted field trials of biotech crops, the penultimate step prior to approval for commercialisation," he noted.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG012532

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel